GNH USA

Europe — EMA

Nipruss (Sodium Nitroprusside Dihydrate)

GNH USA supplies Nipruss (Sodium Nitroprusside), a vasodilator for hypertensive emergencies, acute heart failure and surgical hypotension.

Sodium Nitroprusside Dihydrate

Request sourcing

1
Pack/s

What is Sodium Nitroprusside Dihydrate?

Sodium nitroprusside, the active ingredient in Nipruss, is a vasodilator presented as an intravenous solution for intravenous use. It is employed in the management of hypertensive emergencies, acute heart failure, and controlled hypotension during surgery.

GNH USA supplies Nipruss as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide. The product conforms to EU regulatory standards and is distributed under strict quality‑assurance protocols.

What is Sodium Nitroprusside Dihydrate used for?

Sodium nitroprusside is a rapid‑acting vasodilator used in critical cardiovascular conditions.

- Hypertensive emergencies: rapid reduction of severe blood pressure to target levels. - Acute heart failure: decreases preload and afterload to improve cardiac output. - Controlled hypotension during surgery: maintains a low arterial pressure to reduce intra‑operative bleeding.

What are the side effects of Sodium Nitroprusside Dihydrate?

Sodium nitroprusside may be associated with several adverse reactions, ranging from frequent to rare.

Common Side Effects: - Headache: transient throbbing pain. - Nausea: mild to moderate upset stomach. - Flushing: warm sensation and skin reddening. - Hypotension: excessive drop in blood pressure. Serious or Rare Side Effects: - Cyanide toxicity: accumulation leading to metabolic acidosis. - Severe hypotension with organ hypoperfusion. - Cardiac arrhythmias: irregular heart rhythms.

What precautions apply to Sodium Nitroprusside Dihydrate?

When using sodium nitroprusside, several precautions should be observed to minimize risks.

- Continuous blood pressure monitoring: adjust infusion to avoid rapid drops. - Baseline methemoglobin assessment: patients with G6PD deficiency are at higher risk. - Avoid concurrent cyanide‑releasing agents: reduces clearance of cyanide. - Ensure resuscitation equipment is available: manage sudden profound hypotension. - Store at controlled room temperature: keep in original container, protect from light and moisture.

What does Sodium Nitroprusside Dihydrate interact with?

Sodium nitroprusside can interact with other medicines, affecting its safety and efficacy.

Major Interactions (Avoid): - Co‑administration with other potent vasodilators (e.g., nitroglycerin): may cause profound hypotension. - Combination with antihypertensive agents such as ACE inhibitors, ARBs or diuretics: additive blood pressure lowering. Moderate Interactions (Monitor Closely): - Use with phosphodiesterase inhibitors (e.g., sildenafil): increased vasodilation risk. - Concurrent beta‑blockers: may mask tachycardia response. - Diuretics: may enhance volume depletion and hypotension.

Frequently asked questions

What is Nipruss used for?+
Nipruss contains sodium nitroprusside, a rapid‑acting vasodilator that is used in hypertensive emergencies, acute heart failure, and to produce controlled hypotension during surgical procedures. It works by relaxing arterial and venous smooth muscle, allowing clinicians to quickly lower blood pressure and reduce cardiac workload in critical care settings.
How does sodium nitroprusside work?+
Sodium nitroprusside releases nitric oxide when it enters the bloodstream. The nitric oxide stimulates soluble guanylate cyclase, increasing cyclic GMP levels in vascular smooth muscle. Elevated cyclic GMP leads to smooth‑muscle relaxation, causing dose‑dependent dilation of both arterioles and veins, which reduces preload, afterload, and systemic blood pressure.
What is the usual dose of Nipruss?+
The dosing of Nipruss is individualized and must be determined by the prescribing clinician. Infusion rates are titrated to the patient’s hemodynamic response, with continuous blood‑pressure monitoring to achieve the desired therapeutic target while avoiding excessive hypotension.
Is Nipruss safe during pregnancy or breastfeeding?+
Safety data for sodium nitroprusside in pregnancy and lactation are limited. It should only be used when the potential maternal benefit justifies any possible risk to the fetus or infant, and the decision must be made by the treating physician in consultation with obstetric specialists.
How do I order Nipruss from GNH USA?+
To request Nipruss, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA supplies hospitals, pharmacies and procurement teams worldwide, and will verify trade or institutional credentials before providing pricing, availability, shipping details (including any cold‑chain requirements), and import documentation.
How does Nipruss compare with other antihypertensive agents?+
Compared with agents such as nitroglycerin or hydralazine, sodium nitroprusside provides a more rapid and controllable reduction in both arterial and venous pressure, making it especially useful in emergencies and intra‑operative settings. However, it requires careful monitoring for cyanide accumulation, a risk that is less prominent with many alternative vasodilators.
What are the storage and handling requirements for Nipruss?+
Nipruss should be stored at controlled room temperature, ideally below 25 °C, in its original container. Protect the solution from direct light, moisture and extreme temperature fluctuations. Once prepared, the infusion should be used promptly and any unused portion discarded according to local regulations.
How is Nipruss administered?+
Nipruss is supplied as an intravenous solution and is administered by continuous infusion through a calibrated infusion pump. The infusion rate is adjusted based on real‑time blood‑pressure measurements, and the drug is typically diluted in a compatible carrier fluid before administration.
What are the most serious risks associated with Nipruss?+
The most critical adverse events include cyanide toxicity, which can lead to metabolic acidosis and organ dysfunction, severe hypotension causing inadequate tissue perfusion, and cardiac arrhythmias. Early detection through clinical monitoring and laboratory testing is essential to mitigate these risks.
Who should not use Nipruss?+
Nipruss is contraindicated in patients with known hypersensitivity to sodium nitroprusside or its excipients, those with severe anemia, uncompensated hypoxia, or significant vitamin B12 deficiency that impairs cyanide metabolism. Caution is also advised in patients with pre‑existing methemoglobinemia or severe renal/hepatic impairment.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Sodium Nitroprusside Dihydrate
Route
Intravenous Use
Manufacturer
Altamedics Gmbh
Origin
EU

Related products

Nipruss

Nipruss

Sodium Nitroprusside Dihydrate

Altamedics Gmbh
EU
Nipruss

Nipruss

Sodium Nitroprusside Dihydrate

Altamedics Gmbh
EU
Nipruss

Nipruss

Sodium Nitroprusside Dihydrate

Oresund Pharma Aps
EU
Nipruss

Nipruss

Sodium Nitroprusside Dihydrate

Oresund Pharma Aps
EU